Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan Yee Lau

Showing results (291-300 of 395) with videos related to

Pageof 40
Sort By:
The Oncologist|June 22, 2024
Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patientsMingda Wang, Guojun Qian, Hongmei Xiao, et al.
Annals of Medicine|December 21, 2023
Cardiorespiratory fitness and morbidity and mortality in patients with non-small cell lung cancer: a prospective study with propensity score weightingYaoshan Dun, Ni Cui, Shaoping Wu, et al.
Gastroenterology Report|June 29, 2023
Liver resection versus liver transplantation for hepatocellular carcinoma within the Milan criteria based on estimated microvascular invasion risksPinghua Yang, Fei Teng, Shilei Bai, et al.
International Journal of Surgery (London, England)|March 28, 2023
Association of severity in the grading of microvascular invasion with long-term oncological prognosis after liver resection for early-stage hepatocellular carcinoma: a multicenter retrospective cohort study from a hepatitis B virus-endemic areaXin-Fei Xu, Yong-Kang Diao, Yong-Yi Zeng, et al.
Hepatology International|April 15, 2023
Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched studyShi-Ye Yang, Jin-Kai Feng, Mao-Lin Yan, et al.
Ebiomedicine|May 17, 2018
Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition PathwayQifei Zou, Ying Hou, Haibo Wang, et al.
Frontiers in Oncology|March 27, 2023
Case report: A <i>de novo</i> ERBB3 mutation develops in a gallbladder cancer patient carrying BRCA1 mutation after effective treatment with olaparibJing-Xiao Yang, Zi-Yao Jia, Fa-Tao Liu, et al.
Ebiomedicine|August 28, 2016
Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast CancerChang Gong, Weige Tan, Kai Chen, et al.
The Lancet. Gastroenterology & Hepatology|March 14, 2020
Adjuvant <sup>131</sup>I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trialJun Li, Jingliang Xing, Yefa Yang, et al.
Journal of Hepatology|November 15, 2012
Multi-target lentivirus specific to hepatocellular carcinoma: in vitro and in vivo studiesYe-Wei Zhang, Jian Niu, Xiang Lu, et al.
Pageof 40

Showing results (291-300 of 395) with videos related to

Sort By:
Pageof 40
The Oncologist|June 22, 2024
Prognostic significance of postoperative serological incomplete conversion of AFP and PIVKA-II after hepatic resection for hepatocellular carcinoma: a multicenter analysis of 1755 patientsMingda Wang, Guojun Qian, Hongmei Xiao, et al.
Annals of Medicine|December 21, 2023
Cardiorespiratory fitness and morbidity and mortality in patients with non-small cell lung cancer: a prospective study with propensity score weightingYaoshan Dun, Ni Cui, Shaoping Wu, et al.
Gastroenterology Report|June 29, 2023
Liver resection versus liver transplantation for hepatocellular carcinoma within the Milan criteria based on estimated microvascular invasion risksPinghua Yang, Fei Teng, Shilei Bai, et al.
International Journal of Surgery (London, England)|March 28, 2023
Association of severity in the grading of microvascular invasion with long-term oncological prognosis after liver resection for early-stage hepatocellular carcinoma: a multicenter retrospective cohort study from a hepatitis B virus-endemic areaXin-Fei Xu, Yong-Kang Diao, Yong-Yi Zeng, et al.
Hepatology International|April 15, 2023
Laparoscopic and open liver resection for hepatocellular carcinoma with type 2 diabetes mellitus: multicenter propensity score-matched studyShi-Ye Yang, Jin-Kai Feng, Mao-Lin Yan, et al.
Ebiomedicine|May 17, 2018
Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition PathwayQifei Zou, Ying Hou, Haibo Wang, et al.
Frontiers in Oncology|March 27, 2023
Case report: A <i>de novo</i> ERBB3 mutation develops in a gallbladder cancer patient carrying BRCA1 mutation after effective treatment with olaparibJing-Xiao Yang, Zi-Yao Jia, Fa-Tao Liu, et al.
Ebiomedicine|August 28, 2016
Prognostic Value of a BCSC-associated MicroRNA Signature in Hormone Receptor-Positive HER2-Negative Breast CancerChang Gong, Weige Tan, Kai Chen, et al.
The Lancet. Gastroenterology & Hepatology|March 14, 2020
Adjuvant <sup>131</sup>I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trialJun Li, Jingliang Xing, Yefa Yang, et al.
Journal of Hepatology|November 15, 2012
Multi-target lentivirus specific to hepatocellular carcinoma: in vitro and in vivo studiesYe-Wei Zhang, Jian Niu, Xiang Lu, et al.
Pageof 40